Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

In tests with mice, a protein derived from the virus boosted the immune system's ability to kill cancer cells.

Researchers are trying to better understand how co-mutations and PD-L1 expression impact response to single-agent KRAS G12C ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Combination treatment could also benefit patients with lung, bowel, pancreatic and other solid cancers who don’t respond to ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...